Some two billion possible agents are going to be tested during the world’s largest computer-aided screening project.
Styrian research is again attracting international attention with its research on the coronavirus: The biotech company Innophore, the University of Graz, the Austrian Centre of Industrial Biotechnology and the renowned Harvard University are launching a project together. Innophore’s Catalophore platform will be used for computer-aided screening of around two billion potential active substances against COVID-19.
The Google parent company, Alphabet contributes unlimited Google Cloud computing power to allow the simulation of such a vast number of agents for the first time in history.
“In virtual drug discovery at this scale, the biggest challenge is not only to obtain the data for these billions of compounds, but computing power. At the moment we assume that we have to perform more than 100 billion individual computations as every potential compound is being screened individually. We are delighted to receive Austrian and international support from the Vienna Scientific Cluster and Alphabet, respectively,” says Christian Gruber, CEO of Innophore